131 related articles for article (PubMed ID: 8894306)
1. N alpha-acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant.
Babizhayev MA; Yermakova VN; Sakina NL; Evstigneeva RP; Rozhkova EA; Zheltukhina GA
Clin Chim Acta; 1996 Oct; 254(1):1-21. PubMed ID: 8894306
[TBL] [Abstract][Full Text] [Related]
2. The natural histidine-containing dipeptide Nalpha-acetylcarnosine as an antioxidant for ophthalmic use.
Babizhayev MA; Yermakova VN; Semiletov YA; Deyev AI
Biochemistry (Mosc); 2000 May; 65(5):588-98. PubMed ID: 10851037
[TBL] [Abstract][Full Text] [Related]
3. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
Babizhayev MA
Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of intraocular absorption and drug metabolism of N-acetylcarnosine lubricant eye drops: drug interaction with sight threatening lipid peroxides in the treatment for age-related eye diseases.
Babizhayev MA
Drug Metabol Drug Interact; 2009; 24(2-4):275-323. PubMed ID: 20408504
[TBL] [Abstract][Full Text] [Related]
5. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
Babizhayev MA; Kasus-Jacobi A
Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
[TBL] [Abstract][Full Text] [Related]
6. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.
Babizhayev MA
Drug Dev Ind Pharm; 2008 Oct; 34(10):1071-89. PubMed ID: 18777243
[TBL] [Abstract][Full Text] [Related]
7. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
Babizhayev MA
Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients.
Babizhayev MA; Micans P; Guiotto A; Kasus-Jacobi A
Am J Ther; 2009; 16(6):517-33. PubMed ID: 19487926
[TBL] [Abstract][Full Text] [Related]
9. Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique.
Babizhayev MA; Yegorov YE
Recent Pat Drug Deliv Formul; 2016; 10(2):82-129. PubMed ID: 26084629
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population.
Babizhayev MA; Burke L; Micans P; Richer SP
Clin Interv Aging; 2009; 4():31-50. PubMed ID: 19503764
[TBL] [Abstract][Full Text] [Related]
11. N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications.
Babizhayev MA; Guiotto A; Kasus-Jacobi A
J Drug Target; 2009 Jan; 17(1):36-63. PubMed ID: 19037813
[TBL] [Abstract][Full Text] [Related]
12. Biological activities of the natural imidazole-containing peptidomimetics n-acetylcarnosine, carcinine and L-carnosine in ophthalmic and skin care products.
Babizhayev MA
Life Sci; 2006 Apr; 78(20):2343-57. PubMed ID: 16388826
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
Babizhayev MA
Cell Biochem Funct; 2011 Apr; 29(3):183-206. PubMed ID: 21381059
[TBL] [Abstract][Full Text] [Related]
14. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes.
Babizhayev MA; Deyev AI; Yermakova VN; Brikman IV; Bours J
Drugs R D; 2004; 5(3):125-39. PubMed ID: 15139774
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
Babizhayev MA
Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of oxidative stress and cataract. Novel drug delivery therapeutic strategies targeting telomere reduction and the expression of telomerase activity in the lens epithelial cells with N-acetylcarnosine lubricant eye drops: anti-cataract which helps to prevent and treat cataracts in the eyes of dogs and other animals.
Babizhayev MA; Yegorov YE
Curr Drug Deliv; 2014; 11(1):24-61. PubMed ID: 24783234
[TBL] [Abstract][Full Text] [Related]
17. Novel intraocular and systemic absorption drug delivery and efficacy of N-acetylcarnosine lubricant eye drops or carcinine biologics in pharmaceutical usage and therapeutic vision care.
Babizhayev MA; Khoroshilova-Maslova IP; Kasus-Jacobi A
Fundam Clin Pharmacol; 2012 Oct; 26(5):644-78. PubMed ID: 21793899
[TBL] [Abstract][Full Text] [Related]
18. Ocular pharmacokinetics of carnosine 5% eye drops following topical application in rabbit.
Tianyang Z; Ling Z; Liya W; Junjie Z
J Ocul Pharmacol Ther; 2011 Feb; 27(1):93-7. PubMed ID: 20085487
[TBL] [Abstract][Full Text] [Related]
19. Current ocular drug delivery challenges for N-acetylcarnosine: novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationships.
Babizhayev MA
Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):229-65. PubMed ID: 19534670
[TBL] [Abstract][Full Text] [Related]
20. Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma.
Babizhayev MA
BBA Clin; 2016 Dec; 6():49-68. PubMed ID: 27413694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
